Showing results (441-450 of 491) with videos related to
Sort By:
Pageof 50
Circulation|July 16, 2013
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrelMatthew T Roe, Shaun G Goodman, E Magnus Ohman, et al.European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2023
Antithrombotic treatment strategies in patients with established coronary atherosclerotic diseaseMarco Valgimigli, Victor Aboyans, Dominick Angiolillo, et al.Scientific Reports|August 22, 2022
Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomesChing-Hui Sia, Huili Zheng, Junsuk Ko, et al.Circulation|April 1, 2020
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS TrialDeepak L Bhatt, John W Eikelboom, Stuart J Connolly, et al.Journal of the American College of Cardiology|December 10, 2013
Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)Shaun G Goodman, Daniel M Wojdyla, Jonathan P Piccini, et al.Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary InterventionJoshua P Loh, Li-Ling Tan, Huili Zheng, et al.Circulation|March 18, 2020
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)Kevin R Bainey, Robert C Welsh, Stuart J Connolly, et al.Heart (British Cardiac Society)|January 13, 2021
Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trialAnnette Marie Maznyczka, Peter McCartney, Patrycja Duklas, et al.Lancet (London, England)|August 20, 2013
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trialStephen D Wiviott, Harvey D White, E Magnus Ohman, et al.Circulation|September 13, 2019
Bleeding and New Cancer Diagnosis in Patients With AtherosclerosisJohn W Eikelboom, Stuart J Connolly, Jacqueline Bosch, et al.Pageof 50